Autoantibodies against PTM proteins as biomarkers for lupus

Autoantibodies against post-translationally modified proteins (PTM) are described in various rheumatic diseases and facilitate diagnosis and patient stratification. Researchers from the Leiden University Medical Center analysed the presence of autoantibodies against six different post-translational modifications in a cohort of patients with neuropsychiatric lupus. In this podcast, Leendert Trouw, Rory Monahan and Michelle van den Beukel discuss the results of their study with the ARD/RMDopen social media advisor Caroline Ospelt.Read the Open Access related paper: https://rmdopen.bmj.com/content/8/1/e002079

Listen to more episodes of RMD Open: https://podcasts.apple.com/gb/podcast/rmd-open-rheumatic-and-musculoskeletal-diseases/id1237127864

The RMD Open podcast offers the latest insights in musculoskeletal disorders, rheumatism and connective tissue diseases. Each episode features in-depth interviews with authors and leading experts, discussing the latest research and treatments in the field.

RMD Open - rmdopen.bmj.com - is an esteemed international journal from the BMJ Group publishing original research on the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation.

Stay ahead in your field by tuning into our expert discussions and accessing cutting-edge content.

• No. of episodes: 17
• Latest episode: 2023-02-21
• Health & Fitness Medicine

Where can you listen?